News

Immunotherapy shows promise in metastatic cervical cancer

Publish date: June 4, 2014

 

AT THE ASCO ANNUAL MEETING 2014

The study was supported by the National Cancer Institute, National Institutes of Health. The authors and Dr. Dizon reported no financial disclosures.

pwendling@frontlinemedcom.com

Pages

Recommended Reading

First ASCO survivor care guidelines tackle fatigue, anxiety/depression, neuropathy
MDedge ObGyn
Does the LNG-IUS treat endometrial hyperplasia as effectively as MPA?
MDedge ObGyn
2014 Update on cervical disease
MDedge ObGyn
P4 Medicine: A new approach to health and disease
MDedge ObGyn
Topical lidocaine reduces menopausal dyspareunia
MDedge ObGyn
AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics
MDedge ObGyn
Transvaginal ultrasonography of ovarian cyst
MDedge ObGyn
Hemorrhagic ovarian cysts: One entity with many appearances
MDedge ObGyn
Gynecologic cancer patients treated at high-volume hospitals live longer
MDedge ObGyn
ASCO: Extend adjuvant endocrine therapy to 10 years
MDedge ObGyn